Show simple item record

Pharmacogenomic associations of adverse drug reactions in asthma : systematic review and research prioritisation

dc.contributor.authorKing, Charlotte
dc.contributor.authorMcKenna, Amanda
dc.contributor.authorFarzan, Niloufar
dc.contributor.authorVijverberg, Susanne J.
dc.contributor.authorvan der Schee, Marc P.
dc.contributor.authorMaitland-van der Zee, Anke H.
dc.contributor.authorArianto, Lambang
dc.contributor.authorBisgaard, Hans
dc.contributor.authorBØnnelykke, Klaus
dc.contributor.authorBerce, Vojko
dc.contributor.authorPotočnik, Uroš
dc.contributor.authorRepnik, Katja
dc.contributor.authorCarleton, Bruce
dc.contributor.authorDaley, Denise
dc.contributor.authorChew, Fook Tim
dc.contributor.authorChiang, Wen Chin
dc.contributor.authorSio, Yang Yie
dc.contributor.authorCloutier, Michelle M.
dc.contributor.authorDen Dekker, Herman T.
dc.contributor.authorDuijts, Liesbeth
dc.contributor.authorde Jongste, Johan C.
dc.contributor.authorDijk, F. Nicole
dc.contributor.authorKoppelman, Gerard H.
dc.contributor.authorFlores, Carlos
dc.contributor.authorHernandez-Pacheco, Natalia
dc.contributor.authorPino-Yanes, Maria
dc.contributor.authorMukhopadhyay, Somnath
dc.contributor.authorBasu, Kaninika
dc.contributor.authorBignell, Lauren
dc.contributor.authorTantisira, Kelan G.
dc.contributor.authorTurner, Steve
dc.contributor.authorVerhamme, Katia M.
dc.contributor.authorFrancis, Ben
dc.contributor.authorPirmohamed, Munir
dc.contributor.authorSinha, Ian
dc.contributor.authorHawcutt, Daniel B.
dc.date.accessioned2020-03-06T12:20:01Z
dc.date.available2020-03-06T12:20:01Z
dc.date.issued2020-10
dc.identifier.citationKing , C , McKenna , A , Farzan , N , Vijverberg , S J , van der Schee , M P , Maitland-van der Zee , A H , Arianto , L , Bisgaard , H , BØnnelykke , K , Berce , V , Potočnik , U , Repnik , K , Carleton , B , Daley , D , Chew , F T , Chiang , W C , Sio , Y Y , Cloutier , M M , Den Dekker , H T , Duijts , L , de Jongste , J C , Dijk , F N , Koppelman , G H , Flores , C , Hernandez-Pacheco , N , Pino-Yanes , M , Mukhopadhyay , S , Basu , K , Bignell , L , Tantisira , K G , Turner , S , Verhamme , K M , Francis , B , Pirmohamed , M , Sinha , I & Hawcutt , D B 2020 , ' Pharmacogenomic associations of adverse drug reactions in asthma : systematic review and research prioritisation ' , Pharmacogenomics Journal , vol. 20 , pp. 621-628 . https://doi.org/10.1038/s41397-019-0140-yen
dc.identifier.issn1470-269X
dc.identifier.otherPURE: 158292984
dc.identifier.otherPURE UUID: f57269a2-159c-441a-a11e-6d9400880a72
dc.identifier.otherScopus: 85078235110
dc.identifier.otherPubMed: 31949291
dc.identifier.otherWOS: 000508151600002
dc.identifier.urihttps://hdl.handle.net/2164/13831
dc.descriptionWe would like to thank the NIHR Collaboration for Leadership in Applied Health Research and Care North West Coast (CLAHRC) for funding Amanda McKenna’s internship, and Charlotte Kings MPhil, and the members of the PiCA consortia for their help in completing the survey. U. Potočnik, K. Repnik and V. Berce were supported by SysPharmPedia grant, co-financed by Ministry of Education, Science and Sport of the Republic of Slovenia Author information These authors contributed equally: Charlotte King, Amanda McKenna These authors jointly supervised this work: Ian Sinha, Daniel B. Hawcutten
dc.format.extent8
dc.language.isoeng
dc.relation.ispartofPharmacogenomics Journalen
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.en
dc.subjectCHILDRENen
dc.subjectEXACERBATIONSen
dc.subjectRISKen
dc.subjectPOLYMORPHISMen
dc.subjectBURDENen
dc.subjectRS Pharmacy and materia medicaen
dc.subjectGeneticsen
dc.subjectMolecular Medicineen
dc.subjectPharmacologyen
dc.subjectNational Institute for Health Research (NIHR)en
dc.subjectCLAHRCen
dc.subject.lccRSen
dc.titlePharmacogenomic associations of adverse drug reactions in asthma : systematic review and research prioritisationen
dc.typeJournal itemen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Grampian Data Safe Haven (DaSH)en
dc.contributor.institutionUniversity of Aberdeen.Farr Aberdeenen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1038/s41397-019-0140-y
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85078235110&partnerID=8YFLogxKen
dc.identifier.vol20en


Files in this item

Thumbnail
Name:
King_etal_PJ_Phrmacogenomic_VOR.pdf
Size:
842.5Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record